GS
AVNS icon

GAM Systematic’s Avanos Medical AVNS Stock Holding History

GAM Systematic’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$240K Buy
+5,332
New +$228K 0.03% 493
2017
Q1 		– Sell
-13,909
Closed -$514K – 590
2016
Q4 		$514K Sell
13,909
-1,916
-12% -$68.5K 0.12% 321
2016
Q3 		$548K Buy
+15,825
New +$554K 0.11% 346
2015
Q4 		– Sell
-998
Closed -$28K – 635
2015
Q3 		$28K Buy
+998
New +$34.8K 0.01% 595

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GAM Systematic's AVNS Position: Q3 2017 in Review

GAM Systematic opened a new position in Avanos Medical (AVNS) in Q3 2017: 5,332 shares worth $240K. The stake represents 0.03% of the portfolio and ranks #493 among its holdings. This is a return to the name: GAM Systematic previously reported a position in AVNS as recently as Q4 2016.

GAM Systematic first reported a position in AVNS in Q3 2015 and has held it in 4 quarters since. The position peaked at $548K in Q3 2016. 318 funds tracked by Wall St. Rank hold AVNS as of Q3 2017.

  • GAM Systematic held 5,332 shares of Avanos Medical worth $240K as of Q3 2017.
  • Avanos Medical was a new GAM Systematic position in Q3 2017.
  • Avanos Medical made up 0.03% of GAM Systematic's portfolio in Q3 2017, its #493 holding.
  • GAM Systematic first reported a position in Avanos Medical in Q3 2015 and has held it in 4 quarters since.
  • GAM Systematic's Avanos Medical position peaked at $548K in Q3 2016.
  • 318 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.